$0.240000
At close: Nov 22, 3:23 PM EDT
Comments
Loading...
Ayala Pharmaceuticals (OTC:ADXS) Stock, Earnings Estimates, EPS, And Revenue
Ayala Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 10
EPS
$-2.530
Quarterly Revenue
$0K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$13K
Analyze the earnings history of Ayala Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Ayala Pharmaceuticals (ADXS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2021 | 2021-09-10 | $-0.02 | $-0.04 | 50.0 % |
| Mar 2021 | 2021-06-14 | $-0.04 | $-0.04 | 0.00 % |
| Mar 2020 | 2020-06-11 | $-0.10 | $-0.15 | 33.3 % |
Ayala Pharmaceuticals (ADXS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Ayala Pharmaceuticals (OTCEM:ADXS) reporting earnings?
Ayala Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 10, 2023 for Q4.
What were the latest earnings per share (EPS) for Ayala Pharmaceuticals (OTCEM:ADXS)?
Ayala Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 10, 2023 for Q4 and the Actual EPS was $-2.53, which missed the estimate of $0.00.
What were Ayala Pharmaceuticals’s (OTCEM:ADXS) revenues?
Ayala Pharmaceuticals ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on February 10, 2023 for Q4 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.